Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.7K Buy
5,206
+160
+3% +$3.08K ﹤0.01% 1962
2026
Q2
$92.7K Sell
5,046
-117
-2% -$2.5K ﹤0.01% 1864
2026
Q1
$104K Sell
5,163
-36
-0.7% -$801 ﹤0.01% 1638
2025
Q4
$99.7K Buy
5,199
+764
+17% +$16.1K 0.01% 1582
2025
Q3
$107K Buy
4,435
+354
+9% +$8.27K 0.01% 1459
2025
Q2
$79.4K Buy
4,081
+1,846
+83% +$27.3K 0.01% 1608
2025
Q1
$28.7K Buy
2,235
+1,367
+157% +$22K ﹤0.01% 2185
2024
Q4
$15K Buy
868
+666
+330% +$13.3K ﹤0.01% 2417
2024
Q3
$4.56K Sell
202
-10
-5% -$229 ﹤0.01% 2781
2024
Q2
$5.24K Sell
212
-303
-59% -$8.6K ﹤0.01% 2557
2024
Q1
$17K Sell
515
-41
-7% -$1.4K ﹤0.01% 1757
2023
Q4
$19.3K Buy
+556
New +$19.1K 0.01% 1534

Other funds holding ADNT

GAMMA Investing's ADNT Position: Q3 2026 in Review

GAMMA Investing increased its Adient (ADNT) stake by 3.2% in Q3 2026, buying an estimated $3.08K and bringing the position to 5,206 shares worth $87.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

GAMMA Investing first reported a position in ADNT in Q4 2023 and has held it in 12 quarters since. The position peaked at $107K in Q3 2025. 12 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • GAMMA Investing held 5,206 shares of Adient worth $87.7K as of Q3 2026.
  • GAMMA Investing bought 160 Adient shares in Q3 2026, an estimated $3.08K.
  • Adient made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1962 holding.
  • GAMMA Investing first reported a position in Adient in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Adient position peaked at $107K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.